Importer of Controlled Substances Application: Janssen Pharmaceutical, Inc., 45306-45307 [2016-16551]
Download as PDF
<![CDATA[
45306
Federal Register / Vol. 81, No. 134 / Wednesday, July 13, 2016 / Notices
On June 10, 2016, Complainants
moved to terminate the investigation
based on their withdrawal of the
complaint. No party responded to the
motion.
On June 14, 2016, the ALJ issued the
subject ID, granting Complainants’
motion and terminating the
investigation. No petitions for review
were filed.
The Commission has determined not
to review the subject ID.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in Part
210 of the Commission’s Rules of
Practice and Procedure (19 CFR part
210).
By order of the Commission.
Issued: July 7, 2016.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2016–16523 Filed 7–12–16; 8:45 am]
BILLING CODE 7020–02–P
INTERNATIONAL TRADE
COMMISSION
[Investigation No. 731–TA–287 (Second
Review)]
Raw In-Shell Pistachios From Iran;
Notice of Commission Determination
To Conduct a Full Five-Year Review
United States International
Trade Commission.
ACTION: Notice.
AGENCY:
The Commission hereby gives
notice that it will proceed with a full
review pursuant to the Tariff Act of
1930 to determine whether revocation of
the antidumping duty order on raw inshell pistachios from Iran would be
likely to lead to continuation or
recurrence of material injury within a
reasonably foreseeable time. A schedule
for the review will be established and
announced at a later date.
DATES: Effective Date: July 5, 2016.
FOR FURTHER INFORMATION CONTACT:
Chris Cassise (202) 708–5408, Office of
Investigations, U.S. International Trade
Commission, 500 E Street SW.,
Washington, DC 20436. Hearingimpaired persons can obtain
information on this matter by contacting
the Commission’s TDD terminal on 202–
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at 202–205–2000.
General information concerning the
Commission may also be obtained by
accessing its Internet server (https://
jstallworth on DSK7TPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
15:08 Jul 12, 2016
Jkt 238001
www.usitc.gov). The public record for
this review may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov.
For further information concerning
the conduct of this review and rules of
general application, consult the
Commission’s Rules of Practice and
Procedure, part 201, subparts A through
E (19 CFR part 201), and part 207,
subparts A, D, E, and F (19 CFR part
207).
SUPPLEMENTARY INFORMATION: On July 5,
2016, the Commission determined that
it should proceed to a full review in the
subject five-year review pursuant to
section 751(c) of the Tariff Act of 1930
(19 U.S.C. 1675(c)). The Commission
found that the domestic interested party
group response to its notice of
institution (81 FR 18882, April 1, 2016)
was adequate. Although the
Commission received a response to its
notice of institution from respondent
interested parties, the Commission
found that the respondent interested
party group response with respect to the
reviews on subject imports from Iran
was inadequate.1 The Commission also
found that other circumstances
warranted conducting a full review. A
record of the Commissioners’ votes, the
Commission’s statement on adequacy,
and any individual Commissioner’s
statements will be available from the
Office of the Secretary and at the
Commission’s Web site.
Authority: This review is being conducted
under authority of title VII of the Tariff Act
of 1930; this notice is published pursuant to
section 207.62 of the Commission’s rules.
By order of the Commission.
Issued: July 7, 2016.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2016–16525 Filed 7–12–16; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Janssen Pharmaceutical,
Inc.
accordance with 21 CFR 1301.34(a) on
or before August 12, 2016. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before August 12,
2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/ODW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers
importers, and exporters of, controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on April
11, 2016, Janssen Pharmaceutical, Inc.,
1440 Olympic Drive, Athens, Georgia
30601 applied to be registered as an
importer of the following basic classes
of controlled substances:
Controlled substance
Schedule
DATES:
Phenylacetone (8501) ..................
Thebaine (9333) ...........................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
1 Commissioner Broadbent determined that the
respondent group response was adequate.
The company plans to import
thebaine derivatives (9333) as reference
standards. The company plans to import
an intermediate form of tapentadol
(9780) to bulk manufacture tapentadol
for distribution to its customers. The
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
E:\FR\FM\13JYN1.SGM
13JYN1
II
II
II
II
Federal Register / Vol. 81, No. 134 / Wednesday, July 13, 2016 / Notices
company plans to import phenylacetone
(8501) and poppy straw concentrate
(9670) to manufacture other controlled
substances.
Dated: July 5, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–16551 Filed 7–12–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
revocation of registration) has been
redelegated to the Deputy Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Deputy Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on April
4, 2016, Noramco, Inc., 1440 Olympic
Drive, Athens, Georgia 30601 applied to
be registered as an importer of the
following basic classes of controlled
substances:
Drug Enforcement Administration
Controlled substance
Schedule
[Docket No. DEA–392]
Phenylacetone (8501) ..................
Thebaine (9333) ...........................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
Importer of Controlled Substances
Application: Noramco, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before August 12, 2016. Such persons
may also file a written request for a
hearing on the application pursuant to
21 CFR 1301.43 on or before August 12,
2016.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/ODW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers
importers, and exporters of, controlled
substances (other than final orders in
connection with suspension, denial, or
DATES:
jstallworth on DSK7TPTVN1PROD with NOTICES
II
II
II
II
VerDate Sep<11>2014
15:08 Jul 12, 2016
Jkt 238001
The company plans to import
thebaine derivatives (9333) as reference
standards. The company plans to import
an intermediate form of tapentadol
(9780) to bulk manufacture tapentadol
for distribution to its customers. The
company plans to import phenylacetone
(8501) and poppy straw concentrate
(9670) to manufacture other controlled
substances.
Dated: July 5, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016–16550 Filed 7–12–16; 8:45 am]
BILLING CODE 4410–09–P
45307
This meeting is also available
telephonically and by WebEx. You must
use a touch-tone phone to participate in
this meeting. Any interested person may
dial the USA toll number 1–630–395–
0279 or toll free number 1–888–989–
4389, Passcode: 3927350 followed by
the # sign for both days. To join via
WebEx, the link is https://
nasa.webex.com/, the meeting number
for July 28 is 991 445 749 and the
password is nacgrc0728* (case
sensitive). The meeting number for July
29 is 998 630 315 and the password is
nacgrc0729+ (case sensitive).
The agenda for the meeting will
include reports from the following:
—Aeronautics Committee
—Human Exploration and Operations
Committee
—Institutional Committee
—Science Committee
—Technology, Innovation and
Engineering Committee
—Ad Hoc Task Force on STEM
Education
Attendees will be required to sign a
register. It is imperative that the meeting
be held on this date to accommodate the
scheduling priorities of the key
participants.
Patricia D. Rausch,
Advisory Committee Management Officer,
National Aeronautics and Space
Administration.
[FR Doc. 2016–16548 Filed 7–12–16; 8:45 am]
BILLING CODE 7510–13–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice: 16–053]
NASA Advisory Council; Meeting
National Aeronautics and
Space Administration.
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, Public
Law 92–463, as amended, the National
Aeronautics and Space Administration
(NASA) announces a meeting of the
NASA Advisory Council.
DATES: Thursday, July 28, 2016, 9:00
a.m.–5:00 p.m., Local Time; and Friday,
July 29, 2016, 9:00 a.m.–12:00 p.m.,
Local Time.
ADDRESSES: Ohio Aerospace Institute,
President’s Room, 22800 Cedar Point
Road, Cleveland, Ohio 44142.
FOR FURTHER INFORMATION CONTACT: Ms.
Marla King, NAC Administrative
Officer, NASA Headquarters,
Washington, DC 20546, (202) 358–1148.
SUPPLEMENTARY INFORMATION: This
meeting will be open to the public up
to the capacity of the meeting room.
SUMMARY:
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
NATIONAL FOUNDATION ON THE
ARTS AND THE HUMANITIES
National Endowment for the
Humanities
Meetings of Humanities Panel
National Endowment for the
Humanities, National Foundation on the
Arts and the Humanities.
ACTION: Notice of meetings.
AGENCY:
The National Endowment for
the Humanities will hold twenty-four
meetings of the Humanities Panel, a
federal advisory committee, during
August, 2016. The purpose of the
meetings is for panel review, discussion,
evaluation, and recommendation of
applications for financial assistance
under the National Foundation on the
Arts and Humanities Act of 1965.
DATES: See SUPPLEMENTARY INFORMATION
section for meeting dates. The meetings
will open at 8:30 a.m. and will adjourn
by 5:00 p.m. on the dates specified
below.
SUMMARY:
E:\FR\FM\13JYN1.SGM
13JYN1
]]>Agencies
[Federal Register Volume 81, Number 134 (Wednesday, July 13, 2016)]
[Notices]
[Pages 45306-45307]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-16551]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: Janssen
Pharmaceutical, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.34(a) on or before August 12, 2016. Such persons may also file a
written request for a hearing on the application pursuant to 21 CFR
1301.43 on or before August 12, 2016.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/ODW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/ODW, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments and requests for hearings on
applications to import narcotic raw material are not appropriate. 72 FR
3417 (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers importers, and exporters of,
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Deputy Assistant Administrator of the DEA Office of Diversion
Control (``Deputy Assistant Administrator'') pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on April
11, 2016, Janssen Pharmaceutical, Inc., 1440 Olympic Drive, Athens,
Georgia 30601 applied to be registered as an importer of the following
basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Phenylacetone (8501)....................... II
Thebaine (9333)............................ II
Poppy Straw Concentrate (9670)............. II
Tapentadol (9780).......................... II
------------------------------------------------------------------------
The company plans to import thebaine derivatives (9333) as
reference standards. The company plans to import an intermediate form
of tapentadol (9780) to bulk manufacture tapentadol for distribution to
its customers. The
[[Page 45307]]
company plans to import phenylacetone (8501) and poppy straw
concentrate (9670) to manufacture other controlled substances.
Dated: July 5, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-16551 Filed 7-12-16; 8:45 am]
BILLING CODE 4410-09-P
